Antibody–Drug Conjugates (ADCs): A Review of Structural Design, Technological Evolution, and Future Perspectives
Antibody–drug conjugates (ADCs) have become an important class of targeted anticancer therapeutics by integrating the tumor selectivity of monoclonal antibodies with the potent cytotoxicity of small-molecule payloads through rational linker design. This review summarizes the structural fundamentals...
שמור ב:
| Principais autores: | , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
MDPI AG
2026-04-01
|
| סדרה: | Molecules |
| נושאים: | |
| גישה מקוונת: | https://www.mdpi.com/1420-3049/31/7/1180 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
